Search results with tag "Locally advanced"
NCCN Guidelines for Patients: Early Non-Small Cell Lung Cancer
www.nccn.orgMar 03, 2021 · 1 Lung cancer basics Early and locally advanced lung cancer Early and locally advanced lung cancer Stage 1 and stage 2 cancers are also described as early-stage cancers. Stage 3 cancers are locally advanced. This book is about the diagnosis and first treatments of stage 1, stage 2, and stage 3 lung cancers. Some early and locally advanced cancers
HIGHLIGHTS OF PRESCRIBING INFORMATION …
www.accessdata.fda.govare unresectable, locally advanced or metastatic. Limitations of Use: AFINITOR is not indicated for the treatment of patients with functional carcinoid tumors. (1.2) Adults with advanced renal cell carcinoma (RCC) after failure of treatment with sunitinib or sorafenib. (1.3) Adults with renal angiomyolipoma and tuberous sclerosis complex (TSC),
prescribing information for AFINITOR/AFINITOR DISPERZ ...
www.novartis.usare unresectable, locally advanced or metastatic. Limitations of Use: AFINITOR is not indicated for the treatment of patients with functional carcinoid tumors. (1.2) Adults with advanced renal cell carcinoma (RCC) after failure of treatment with sunitinib or sorafenib. (1.3) Adults with renal angiomyolipoma and tuberous sclerosis complex (TSC),
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
www.ema.europa.euLENVIMA as monotherapy is indicated for the treatment of adult patients with progressive, locally advanced or metastatic, differentiated (papillary/follicular/Hürthle cell) thyroid carcinoma (DTC), refractory to radioactive iodine (RAI).
Bristol Myers Squibb - Global Biopharmaceutical Company
www.bms.comRenal Cell Carcinoma (RCC) subcutaneous nivolumab + rHuPH20+ OPDIVO@+ (nivolumab) (nivolumab) * YERVOY@+ ... Locally Advanced: 1st line SCCHN Esophageal: 15t line Esophageal: 15t line I st line Pediatric Adjuvant ... SCCHN = Squamous Cell Carcinoma of the Head & Neck HMA = Hypomethylating Agent
LOCALLY ADVANCED SQUAMOUS CARCINOMA OF THE …
www.who.intLOCALLY ADVANCED SQUAMOUS CARCINOMA OF THE HEAD AND NECK Executive Summary The annual incidence of head and neck cancers worldwide is more than 550,000 cases with around 300,000 deaths each year [1]. Male to female ratio ranges from 2:1 to 4:1. About 90% of all head and neck cancers are squamous cell carcinomas (HNSCC). HNSCC is the sixth …